Large-scale testing (Phase 3)UnknownNCT03119857What this trial is testingEarly Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14Who this might be right forProstatic Neoplasms Göteborg University 349
Early research (Phase 1)Study completedNCT00866528What this trial is testingStudy of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung CancerWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 30
Testing effectiveness (Phase 2)Ended earlyNCT00265200What this trial is testingUsing TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung CancerWho this might be right forCarcinoma, Non-Small Cell LungCarcinoma, Small Cell LungMetastases University of Louisville 28
Testing effectiveness (Phase 2)Study completedNCT00003336What this trial is testingPilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic ConditionsWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Active Not RecruitingNCT04194944What this trial is testingSelpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Eli Lilly and Company 261
Not applicableUnknownNCT05848154What this trial is testingApplication of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic CancerWho this might be right forPatients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma Shanghai Zhongshan Hospital 92
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Study completedNCT01108445What this trial is testingPhase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Non-clear Cell Renal Cell Carcinoma Duke University 131
Not applicableWithdrawnNCT04889495What this trial is testingA Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWho this might be right forNon-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more Pfizer
Early research (Phase 1)Study completedNCT00496275What this trial is testingPhase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCWho this might be right forNon Small Cell Lung Cancer Genzyme, a Sanofi Company 17
Testing effectiveness (Phase 2)UnknownNCT02499367What this trial is testingNivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) PatientsWho this might be right forBreast Cancer The Netherlands Cancer Institute 84
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Looking for participantsNCT06512051What this trial is testingA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forAdvanced or Metastatic Non-small Cell Lung Cancer Shanghai Hengrui Pharmaceutical Co., Ltd. 248
Testing effectiveness (Phase 2)UnknownNCT00874328What this trial is testingTS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Who this might be right forAdvanced Non-Small Cell Lung Cancer National Cancer Center, Korea 74
Post-approval studies (Phase 4)Ended earlyNCT02299765What this trial is testingIntercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLCWho this might be right forNon-small Cell Lung Cancer MetastaticEGFR Activating Mutation Sichuan University 61
Large-scale testing (Phase 3)Study completedNCT04923945What this trial is testingSavolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) PatientsWho this might be right forNon-small Cell Lung Cancer Metastatic Hutchison Medipharma Limited 203
Large-scale testing (Phase 3)Study completedNCT03134872What this trial is testingSHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more Jiangsu HengRui Medicine Co., Ltd. 419
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07420439What this trial is testingTreatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung DiseaseWho this might be right forNon Small Cell Lung Cancer MetastaticInterstitial Lung Disease (ILD) Intergroupe Francophone de Cancerologie Thoracique 108
Not applicableStudy completedNCT06013475What this trial is testingAn Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World SettingsWho this might be right forNon-metastatic Castration-resistant Prostate Cancer Bayer 1,375
Post-approval studies (Phase 4)Study completedNCT03451019What this trial is testingDifferent Effects of Non-calcium Phosphate Binders on Serum CalciumWho this might be right forChronic Kidney Disease Medical University of Lodz 34